Medicine and Dentistry
Percutaneous Aortic Valve Replacement
100%
Percutaneous Coronary Intervention
54%
Aortic Valve Replacement
39%
Myocardial Infarction
35%
Acute Coronary Syndrome
31%
Aortic Stenosis
28%
Apoplexy
26%
Drug-Eluting Stent
24%
Aortic Valve
23%
All Cause Mortality
22%
Revascularization
21%
Platelet
19%
Coronary Artery Disease
17%
Acute Heart Infarction
16%
Aortic Valve Prosthesis
16%
Mitral Insufficiency
15%
Abciximab
14%
Surgical Risk
14%
Hazard Ratio
13%
Meta-Analysis
13%
Angioplasty
13%
Platelet Glycoprotein IIb/IIIa
13%
ST Elevation
12%
Heparin
12%
Randomized Clinical Trial
11%
Transluminal Coronary Angioplasty
11%
Antiplatelet
11%
Unstable Angina Pectoris
11%
Acetylsalicylic Acid
10%
Coronary Angiography
10%
Bleeding
10%
Transcatheter Aortic Valve Replacement
10%
Fibrinolytic Therapy
10%
Thrombosis
10%
Fibrinogen Receptor
9%
Hemodynamic
9%
Blood Clot Lysis
9%
Aortic Insufficiency
9%
Placebo
9%
Paravalvular Leak
8%
Eptifibatide
8%
Odds Ratio
8%
Q Wave
8%
Cardiogenic Shock
8%
Clinical Trial
8%
Congestive Heart Failure
8%
Infarction
8%
Glycoprotein IIb/IIIa Inhibitors
8%
Coronary Artery Bypass Graft
8%
Target Lesion Revascularization
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
53%
Acute Coronary Syndrome
44%
Heparin
41%
Fibrinogen Receptor
39%
Acute Heart Infarction
31%
Acetylsalicylic Acid
28%
Abciximab
26%
Coronary Artery Disease
21%
Eptifibatide
21%
All Cause Mortality
20%
Bleeding
19%
Clinical Trial
16%
Antiplatelet
16%
Placebo
15%
Bivalirudin
15%
Cerebrovascular Accident
14%
Fibrinolytic Agent
14%
Infarction
14%
Unstable Angina Pectoris
13%
Clopidogrel
12%
Pharmacodynamics
11%
Aortic Stenosis
10%
Combination Therapy
9%
Tissue Plasminogen Activator
9%
Receptor
9%
Enoxaparin
8%
Congestive Heart Failure
8%
Anticoagulant Agent
8%
Alteplase
8%
Ischemia
7%
Fibrinogen Receptor Antagonist
7%
Thrombin
6%
Thrombosis
6%
Mitral Valve Regurgitation
6%
Antithrombocytic Agent
6%
Heart Muscle Ischemia
5%
Adenosine Diphosphate
5%
Cardiogenic Shock
5%
P-Selectin
5%
Restenosis
5%
Heart Left Bundle Branch Block
5%
Keyphrases
Transcatheter Aortic Valve Replacement
38%
Acute Coronary Syndrome
22%
Percutaneous Coronary Intervention
16%
Surgical Aortic Valve Replacement
15%
Acute Myocardial Infarction
12%
Heparin
11%
Glycoprotein IIb-IIIa
11%
Myocardial Infarction
10%
All-cause Mortality
10%
Aspirin
10%
Transcatheter Aortic Valve Implantation
10%
Stable Angina
9%
Platelet Glycoproteins
9%
Glycoprotein IIb/IIIa Inhibitors
8%
Eptifibatide
8%
Clinical Outcomes
8%
Evolut
8%
Abciximab
8%
Transcatheter Heart Valve
8%
Low-risk Patients
7%
Transcatheter
7%
Revascularization
7%
Platelets
7%
CoreValve
6%
Drug-eluting Stent
6%
Platelet Aggregation
6%
Aortic Stenosis
6%
Meta-analysis
6%
Cardiogenic Shock
6%
Transcatheter Edge-to-edge Repair
6%
Clinical High Risk
6%
Confidence Interval
6%
Randomized Clinical Trial
5%
Coronary Artery Bypass Grafting
5%
Coronary Artery Disease
5%
Thrombolysis
5%
High Risk
5%
Coronary Artery Bypass Graft Surgery
5%
